Literature DB >> 32896230

Chemical Composition of Traditional and Analog Ayahuasca.

Helle Kaasik1, Rita C Z Souza2, Flávia S Zandonadi2, Luís Fernando Tófoli3, Alessandra Sussulini2.   

Abstract

Traditional ayahuasca can be defined as a brew made from Amazonian vine Banisteriopsis caapi and Amazonian admixture plants. Ayahuasca is used by indigenous groups in Amazonia, as a sacrament in syncretic Brazilian religions, and in healing and spiritual ceremonies internationally. The study aimed to determine concentrations of the main bio- and psychoactive components of ayahuasca used in different locations and traditions. We collected 102 samples of brews from ayahuasca-using communities. Concentrations of N,N-dimethyltryptamine (DMT), tetrahydroharmine, harmine, and harmaline were determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS). Qualitative analyses for non-traditional additives (moclobemide, psilocin, yuremamine) were performed by high resolution mass spectrometry. Higher and more variable concentrations of DMT in neoshamanic ayahuasca samples compared to indigenous samples may indicate use of higher and more variable proportions of DMT-containing admixture plants. From European samples, we found two related samples of analog ayahuasca containing moclobemide, psilocin, DMT, yuremamine, and very low concentrations of B. caapi alkaloids. Some analogs of ayahuasca (Peganum harmala, Mimosa tenuiflora) were used in Europe. No analogs were found from Brazil or Santo Daime ceremonies in Europe. We recommend awareness about the constituents of the brew and ethical self-regulation among practitioners of ayahuasca ceremonies.

Entities:  

Keywords:  Ayahuasca; DMT; Daime; harmaline; harmine; tetrahydroharmine

Year:  2020        PMID: 32896230     DOI: 10.1080/02791072.2020.1815911

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  6 in total

Review 1.  Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects.

Authors:  Ľuboš Nižnanský; Žofia Nižnanská; Roman Kuruc; Andrea Szórádová; Ján Šikuta; Anežka Zummerová
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

2.  Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.

Authors:  Daniel Perkins; Violeta Schubert; Hana Simonová; Luís Fernando Tófoli; José Carlos Bouso; Miroslav Horák; Nicole Leite Galvão-Coelho; Jerome Sarris
Journal:  Front Pharmacol       Date:  2021-04-21       Impact factor: 5.810

3.  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Authors:  Joseph M Rootman; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Vince Polito; Francoise Bourzat; Zach Walsh
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

4.  New Insights into the Chemical Composition of Ayahuasca.

Authors:  Luisina Rodríguez; Andrés López; Guillermo Moyna; Gustavo A Seoane; Danilo Davyt; Álvaro Vázquez; Gonzalo Hernández; Ignacio Carrera
Journal:  ACS Omega       Date:  2022-04-01

5.  Amazonian Medicine and the Psychedelic Revival: Considering the "Dieta".

Authors:  David M O'Shaughnessy; Ilana Berlowitz
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

Review 6.  Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.

Authors:  Steven A Barker
Journal:  Psychopharmacology (Berl)       Date:  2022-01-22       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.